National Sports Brain Bank to launch at the University of Pittsburgh
NFL Hall of Famer Jerome Bettis pledges donation to Pitt’s new National Sports Brain Bank
NFL Hall of Famer Jerome Bettis pledges donation to Pitt’s new National Sports Brain Bank
Nearly half (47%) of the participants on donanemab (compared to 29% on placebo) had no clinical progression at 1 year (defined as no decline in CDR-SB)
Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease.
Anantha Shekhar,MD, PHD, Senior Vice Chancellor for the Health Sciences at the University of Pittsburgh announced the winners of the inaugural Ascending Stars Award
Dr. Victor Villemagne, MD, a Professor of Psychiatry and Co-Leader of the Alzheimer’s Disease Research Center’s Neuroimaging Core has been awarded the prestigious 2022 Aging Mind Foundation Award.
The Clear Thoughts Foundation (CTF), a Pittsburgh-based nonprofit dedicated to fighting dementia, has awarded $200,000 to co-investigators as part of the CTF Consortium to begin preclinical research on how melatonin might affect dementia-related processes in the brain.
The Department of Aging convened a gathering of Alzheimer’s Disease researchers from the University of Pennsylvania’s Perelman School of Medicine and the University of Pittsburgh in a daylong forum to share and discuss their latest work in the areas of prevention, treatment and caregiving.
Gdavis Productions & Films in association with the University of Pittsburgh Alzheimer’s Disease Research Center presents the free live streaming of Garrett Davis’ award winning stage play, Forget Me Not.
The aging of the U.S. population and the concurrent rise in the number of adults living with dementia underscore the urgent need for a systematic review of the available evidence for care interventions for PLWD and their formal and informal caregivers. The National Institute on Aging commissioned such a review from the Evidence-based Practice Center Program at the Agency for Healthcare Research and Quality.
NIH approves a $350 million Alzheimer’s and dementia funding increase for fiscal year 2020.
YMAA was charted in 2015 and is the largest youth-led Alzheimer’s 501 (c)(3) non-profit in the nation.
The disease, called LATE, seems to develop more slowly than Alzheimer’s and to appear later, when people are in their 80s and 90s.
Alzheimer’s disease impacts nearly 6 million Americans. Researchers at the University of Pittsburgh are working to try and figure out why and whether it can be stopped. They say it may start with a walk around the block.
What do we know about AD and how do we treat it? Dr. Jennifer Lingler and Niki Kapsambelis talk to Ken Rice and Sally Stapleton on KD/PG Sunday edition.
Nearly two-thirds of Americans living with Alzheimer’s are women. Sixty percent of all Alzheimer’s caregivers are women.
In an online article in Live Science staff writer Yasemin Saplakoglu discusses a recent study suggesting a possible cause of Alzheimer’s disease.
The BRiTE (Brain Training and Exercise) Center mission is to promote the overall health and wellness of older adults who want to optimize their level of cognitive, social, and physical functioning.
Melita Terry, Alzheimer’s Disease Research Center Outreach Coordinator and Dr. Annie Cohen, Assistant Professor of Psychiatry, both at the University of Pittsburgh, spoke about Alzheimer’s disease at the Urban League Lunch and Learn in February, 2018.
Brain Day is an all-day event that brings together experts from around Pitt to share their work in neuroscience with not only their colleagues, but with the patient advocacy community.
A new clinical trials consortium funded by the National Institutes of Health is expected to accelerate and expand studies for therapies in Alzheimer’s disease and related dementias.